Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug;121(4):314-319.
doi: 10.1016/j.ymgme.2017.06.009. Epub 2017 Jun 24.

Analyses of SLC13A5-epilepsy patients reveal perturbations of TCA cycle

Matthew N Bainbridge  1 , Erin Cooney  2 , Marcus Miller  2 , Adam D Kennedy  3 , Jacob E Wulff  3 , Taraka Donti  2 , Shalini N Jhangiani  4 , Richard A Gibbs  4 , Sarah H Elsea  2 , Brenda E Porter  5 , Brett H Graham  6
Affiliations

Analyses of SLC13A5-epilepsy patients reveal perturbations of TCA cycle

Matthew N Bainbridge et al. Mol Genet Metab. 2017 Aug.

Abstract

Objective: To interrogate the metabolic profile of five subjects from three families with rare, nonsense and missense mutations in SLC13A5 and Early Infantile Epileptic Encephalopathies (EIEE) characterized by severe, neonatal onset seizures, psychomotor retardation and global developmental delay.

Methods: Mass spectrometry of plasma, CSF and urine was used to identify consistently dysregulated analytes in our subjects.

Results: Distinctive elevations of citrate and dysregulation of citric acid cycle intermediates, supporting the hypothesis that loss of SLC13A5 function alters tricarboxylic acid cycle (TCA) metabolism and may disrupt metabolic compartmentation in the brain.

Significance: Our results indicate that analysis of plasma citrate and other TCA analytes in SLC13A5 deficient patients define a diagnostic metabolic signature that can aid in diagnosing children with this disease.

Keywords: Metabolomics; SLC13A5; Seizure; Tricarboxylic acid cycle.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

MNB is a founder of Codified Genomics LLC a variant interpretation company. The other authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Pedigree, disease and mutation status for three families, A, B and C. Hashing indicates disease/carrier status (full/half, respectively).
Figure 2
Figure 2. Citrate is elevated in plasma and CSF in SLC13A5 patients
Box and whisker plots of (A) CSF (n=3) (B) plasma (n=5) and (C) urine (n=4) citrate levels between controls and subjects.
See this image and copyright information in PMC

References

    1. McTague A, Howell KB, Cross JH, Kurian MA, Scheffer IE. The genetic landscape of the epileptic encephalopathies of infancy and childhood. Lancet Neurol. 2016;15:304–316. doi: 10.1016/S1474-4422(15)00250-1. - DOI - PubMed
    1. Dulac O. Epileptic Encephalopathy. Epilepsia. 2001;42:23–26. doi: 10.1046/j.1528-1157.2001.042suppl.3023.x. - DOI - PubMed
    1. Fujiwara T, Sugawara T, Mazaki-Miyazaki E, Takahashi Y, Fukushima K, Watanabe M, Hara K, Morikawa T, Yagi K, Yamakawa K, Inoue Y. Mutations of sodium channel alpha subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic-clonic seizures. Brain J Neurol. 2003;126:531–546. - PubMed
    1. Feucht M, Fuchs K, Pichlbauer E, Hornik K, Scharfetter J, Goessler R, Füreder T, Cvetkovic N, Sieghart W, Kasper S, Aschauer H. Possible association between childhood absence epilepsy and the gene encoding GABRB3. Biol Psychiatry. 1999;46:997–1002. doi: 10.1016/S0006-3223(99)00039-6. - DOI - PubMed
    1. Cassandrini D, Cilio MR, Bianchi M, Doimo M, Balestri M, Tessa A, Rizza T, Sartori G, Meschini MC, Nesti C, Tozzi G, Petruzzella V, Piemonte F, Bisceglia L, Bruno C, Dionisi-Vici C, D’Amico A, Fattori F, Carrozzo R, Salviati L, Santorelli FM, Bertini E. Pontocerebellar hypoplasia type 6 caused by mutations in RARS2: definition of the clinical spectrum and molecular findings in five patients. J Inherit Metab Dis. 2013;36:43–53. doi: 10.1007/s10545-012-9487-9. - DOI - PubMed

Supplementary concepts